The Nordic HILUS-Trial - First Report of a Phase II Trial of SBRT of Centrally Located Lung Tumors

被引：44

作者：

Lindberg, Karin ^{[1
]}

Bergstrom, Per ^{[2
]}

Brustugun, Odd Terje ^{[3
]}

Engelholm, Silke ^{[4
]}

Grozman, Vitali ^{[5
]}

Hoyer, Morten ^{[6
]}

Karlsson, Kristin ^{[5
]}

Khalil, Azza ^{[6
]}

Kristiansen, Charlotte ^{[7
]}

Lax, Ingmar ^{[5
]}

Loden, Britta ^{[8
]}

Nyman, Jan ^{[9
]}

Persson, Gitte ^{[10
]}

Rogg, Lotte ^{[11
]}

Wersall, Peter ^{[5
]}

Lewensohn, Rolf ^{[1
]}

机构：

[1] Karolinska Inst, Oncol & Pathol, Stockholm, Sweden

[2] Norrlands Univ Hosp, Umea, Sweden

[3] Ouh Radiumhosp, Dept Oncol, Oslo, Norway

[4] Skanes Univ Hosp, Lund, Sweden

[5] Karolinska Univ Hosp, Stockholm, Sweden

[6] Aarhus Univ Hosp, Oncol, Aarhus C, Denmark

[7] Odense Univ Hosp, Dept Clin Oncol, Odense C, Denmark

[8] Centralsjukhuset, Karlstad, Sweden

[9] Sahlgrens Univ Hosp, Gothenburg, Sweden

[10] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark

[11] Univ Oslo, Hosp Ulleval, Oslo, Norway

来源：

关键词：

side effects; SBRT; stereotactic; central lung tumors;

D O I：

10.1016/j.jtho.2016.11.369

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA24.05

引用

页码：S340 / S340

页数：1